Developing gene therapy for dominant optic atrophy using human pluripotent stem cell-derived retinal organoid disease models

  • Post author:
  • Post category:

Research Objective We will develop a gene therapy for a major inherited optic nerve disease and test the effectiveness of the treatment by analyzing healthy and patient stem cell-derived mini…

Continue ReadingDeveloping gene therapy for dominant optic atrophy using human pluripotent stem cell-derived retinal organoid disease models

Providing a cure for sphingosine phosphate lyase insufficiency syndrome (SPLIS) through adeno-associated viral mediated SGPL1 gene therapy

  • Post author:
  • Post category:

Research Objective AAV-SPL 2.0 is a gene therapy cure for SPLIS, a lethal childhood disorder of metabolism that causes kidney failure. Our gene therapy may also work in more common…

Continue ReadingProviding a cure for sphingosine phosphate lyase insufficiency syndrome (SPLIS) through adeno-associated viral mediated SGPL1 gene therapy

New noncoding RNA chemical entity for heart failure with preserved ejection fraction.

  • Post author:
  • Post category:

Research Objective Modified synthetic noncoding RNA molecule Impact Heart failure with preserved ejection fraction Major Proposed Activities Lead optimizationPerform extensive preclinical testing and select a therapeutic candidate.Develop and test preliminary…

Continue ReadingNew noncoding RNA chemical entity for heart failure with preserved ejection fraction.